Categories: AnalystsEconomy

This market correction will last two to four weeks, Canaccord Genuity says

The intra-day record drop of more than 1500 points on the Dow Monday might be an outlier, but one analyst says to steel yourself for a correction that could take most of February to complete.

Global equity markets will be facing a short-term corrective phase over the next two to four weeks, says Canaccord Genuity analyst Javed Mirza, who points to monetary policy uncertainty and a recent run of bullishness in the markets as signs of a pull-back.

“Given that we anticipate further near-term equity market weakness, we prefer waiting to add exposure,” says the analyst in a Canadian technical comment. “Our list of open thematic ideas is heavily weighted to bond proxies in anticipation of the current corrective phase. Now we do the toughest thing possible. We wait.”

Mirza says that the S&P500, TSX Composite, Nasdaq 100 and Russell 2000 are all on short-term “mechanical sell” signals, which suggests market weakness over the short term, even as the long-term view remains a bull market.

Mirza says a good run in so-called bond proxies last week will likely continue, further signalling a defensive trend in the markets. Especially in the Materials and Energy space, which the analyst sees as crossing over into a “mechanical sell” this week. “The Resource sectors have deteriorated sharply relative to the TSX Composite over the last two weeks, after having put in a strong performance since December,” says the analyst. “Our view over the last couple of weeks has been that a multi-week corrective phase was pending in the Resource space.”

The analyst recommends adding stocks with improving relative strength over the intermediate term, namely Brookfield Property Partners LP (TSX:BPY.UN) and CGI Group, Inc. (TSX:GIB.A), both of which are showing improving relative performance versus the TSX Composite.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

10 mins ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

19 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

21 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

22 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

23 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

4 days ago